Aurobindo Pharma Limited — Updates, 27-06-2026: General Updates
27-06-2026 | 10:38 am
27-06-2026 | 10:38 am
Aurobindo Pharma's subsidiary, Auroactive Pharma, concluded a US FDA inspection with 2 observations. The company will respond promptly, stating no impact on its financials or operations, maintaining high quality standards.
No comments yet. Be the first to comment!
